Pioneered by experts in REGENERATIVE MEDICINE

Globally-renowned developmental evolutionary and stem cell biologist who studies the genetic basis of skeletal muscle stem cell action during development, evolution, regeneration and disease.

Director of ARMI since 2016, with over 20+ years experience, and 7 patents and multiple licensing deals.

Leader in regenerative medicine including immune-centric regenerative strategies and protein engineering.

With 10 patents and Co-Founder of Orio Therapeutics in 2023, looking ahead Professor Martino remains passionate about creating new therapeutics for regenerative medicine.

Experienced in supporting the development and translation of early-stage medical and pharmaceutical discoveries, from IP identification to post-deal management. Bo has led and supported numerous complex transactions, securing high-value partnerships, licenses and investments with leading industry partners.

Inaugural Chief Commercialisation Officer at Monash University responsible for developing and overseeing the successful IP  commercialisation programs. Director of spin-outs including Amero (IPO 2019).

Senior Director, Enterprise and Partnerships. Business development / admitted lawyer in Australia.

Extensive experience leading biomedical and public health business development activities in universities and medical research institutes.

Global leader in muscular dystrophy pathophysiology and disease models. As Director at the Centre for Muscle Research, his research encompasses muscle growth, adaptation and plasticity and understanding muscle wasting and weakness.

Dr Eppie Yiu is a paediatric neurologist at the Royal Children’s Hospital Melbourne and an honorary fellow at the Murdoch Children’s Research Institute. She has extensive experience as investigator in both investigator-initiated and industry-sponsored clinical drug trials in neuromuscular disorders, with >30 industry and investigator-led clinical trials including DMD, SMA.

Head of Structural Biology of Signalling and Cancer Laboratory, his research is focused on capturing an atomic resolution view of ‘signalling in action’ by determining the structures of protein complexes formed by GTPase-activating proteins (GAP) and guanine nucleotide exchange factors (GEFs). Extensive commercial Fc-fusion expertise and Co-founder of Wolf Bio.